High-dose chemotherapy of metastatic breast cancer: the end of the beginning?
1997

High-dose chemotherapy for metastatic breast cancer

Editorial Evidence: moderate

Author Information

Author(s): J Crown

Primary Institution: St. Vincent's Hospital, Dublin 4, Republic of Ireland

Hypothesis

Can high-dose chemotherapy improve outcomes for patients with metastatic breast cancer?

Conclusion

High-dose chemotherapy may be more effective than standard doses, but only a minority of patients achieve durable remissions.

Supporting Evidence

  • High-dose chemotherapy has shown high response rates but often leads to relapse.
  • Only a small percentage of patients achieve long-lasting remissions with high-dose therapy.
  • Studies indicate that high-dose therapy may be more active than low-dose therapy.

Takeaway

Doctors are trying to give higher doses of chemotherapy to help people with advanced breast cancer, but it doesn't work for everyone.

Methodology

The editorial discusses various studies and strategies involving high-dose chemotherapy and its effects on metastatic breast cancer.

Potential Biases

There is a substantial potential for selection bias in the single-arm studies discussed.

Limitations

The studies reviewed have potential selection bias and the results are not convincingly superior to standard treatments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication